Press Releases
Press Release filters
Sign up to receive updates from mdxhealth
Click the button below to fill in your contact information and receive updates from mdxhealth.
MDxHealth to Receive $2.3 million “Paycheck Protection Program” Loan Under the U.S. CARES Act
NEWS RELEASE IRVINE, CA, and HERSTAL, BELGIUM – April 20, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovat
MDxHealth présente son rapport d’activité pour le 1er trimestre de 2020
COMMUNIQUÉ DE PRESSE — INFORMATIONS RÉGLEMENTÉES IRVINE, CA, et HERSTAL, BELGIQUE – le 9 avril 2020 – MDxHealth SA (Eu
MDxHealth Provides Q1-2020 Business Update
PRESS RELEASE REGULATED INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – April 9, 2020 – MDxHealth SA (Euronext: MDXH.BR), a co
MDxHealth Updates 2020 Reporting Calendar and Provides Initial View on Coronavirus Situation
IRVINE, CA, and HERSTAL, BELGIUM – April 1, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular d
MDxHealth : SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in the 2019 Italian Society of Urology Guidelines
MDxHealth’s SelectMDx® Liquid Biopsy Test for Prostate Cancer Included in the 2019 Italian Society of Urology Guidelines A significant milestone to increase adoption of SelectMDx in
Annual General Shareholders’ Meeting
Annual General Shareholders’ Meeting Annual General Shareholders’ Meeting IRVINE, CA, et HERSTAL, BELGIQUE – 16:00 CEST, May 31,2018 – MDxHealth SA (Euronext : MDXH), held today its
MDxHealth Prepares for Growth with Executive Team Expansion
MDxHealth Prepares for Growth with Executive Team Expansion Michael K. Brawer, MD Appointed as Chief Medical Officer PRESS RELEASE IRVINE, CA, and HERSTAL,
ConfirmMDx Study Provides Further Validation of Epigenetic Risk Profile
ConfirmMDx Study Provides Further Validation of Epigenetic Risk Profile NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION
Extrodinary General Shareholders’ Meeting
Extrodinary General Shareholders’ Meeting IRVINE, CA, and HERSTAL, BELGIUM – 14:30 CEST, June 19 2017 – MDxHealth
MDxHealth Launches CE-Marked SelectMDx IVD PCR Kit and UrNCollect Device
MDxHealth Launches CE-Marked SelectMDx IVD PCR Kit and UrNCollect Device NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION / FOR EX-US ONLY
Annual General Shareholders’ Meeting
IRVINE, CA, and HERSTAL, BELGIUM – 15:45 CEST, May 26 2017 – MDxHealth SA (Euronext: MDXH.BR) held today its Annual General Shareholders’ Meeting in Diegem. The
SelectMDx for Prostate Cancer Guides Patient Selection for mpMRI
SelectMDx for Prostate Cancer Guides Patient Selection for mpMRI NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION ABSTRACT #MP33-17
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men NEWS RELEASE ABSTRACT #PD07-04 IRVINE, CA, and HERSTAL, BELGIUM – 16:00 CEST, May
MDxHealth Trading Update: January to April 2017
MDxHealth Trading Update: January to April 2017 NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION
MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence
MDxHealth Epigenetic Biomarkers Identify Men at Increased Risk of Prostate Cancer Recurrence NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATIONABSTRACT #490, POSTER SESSION 36
MDxHealth Awarded a Federal Supply Schedule Contract for ConfirmMDx for Prostate Cancer
MDxHealth Awarded a Federal Supply Schedule Contract for ConfirmMDx for Prostate Cancer NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION IRVINE, CA, and HERSTAL, BELGIUM – February
MDxHealth Reports Financial Year 2019 Results and Provides Outlook for 2020
Conference call with Q&A today at 09:00 CET / 08:00 GMT, details provided below IRVINE, CA, and HERSTAL, BELGIUM – February
MDxHealth communique ses résultats financiers pour l’exercice 2019 et ses perspectives pour 2020
Conférence téléphonique avec séance de questions-réponses aujourd’hui à 09h00 CEST/08h00 GMT, voir détails ci-dessous
MDxHealth Notice of 2019 Full Year Results
IRVINE, CA, and HERSTAL, BELGIUM – January 10, 2020 – MDxHealth SA (Euronext: MDXH.BR), a commercial-stage innovative molecular diagnostics company, today announced that it will release its financial
MDxHealth présente son rapport d’activité pour le 3e trimestre de 2019
IRVINE, CA, et HERSTAL, BELGIQUE — lundi 11 novembre 2019 — MDxHealth SA (Euronext : MDXH.BR), une société de diagnostic
